Respiri Ltd - Asset Resilience Ratio
Respiri Ltd (RSH) has an Asset Resilience Ratio of 0.46% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Respiri Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Respiri Ltd's Asset Resilience Ratio has changed over time. See Respiri Ltd book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Respiri Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RSH company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$28.49K | 0.46% |
| Total Liquid Assets | AU$28.49K | 0.46% |
Asset Resilience Insights
- Limited Liquidity: Respiri Ltd maintains only 0.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Respiri Ltd Industry Peers by Asset Resilience Ratio
Compare Respiri Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 9.40% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Ok Biotech Co Ltd
TW:4155 |
Medical Devices | 0.32% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Respiri Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Respiri Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 0.46% | AU$28.49K ≈ $20.16K |
AU$6.19 Million ≈ $4.38 Million |
-0.44pp |
| 2023-06-30 | 0.90% | AU$28.49K ≈ $20.16K |
AU$3.18 Million ≈ $2.25 Million |
+0.22pp |
| 2022-06-30 | 0.68% | AU$28.49K ≈ $20.16K |
AU$4.21 Million ≈ $2.98 Million |
-87.26pp |
| 2021-06-30 | 87.94% | AU$8.01 Million ≈ $5.67 Million |
AU$9.11 Million ≈ $6.44 Million |
+86.88pp |
| 2020-06-30 | 1.06% | AU$49.00K ≈ $34.67K |
AU$4.62 Million ≈ $3.27 Million |
-0.16pp |
| 2019-06-30 | 1.22% | AU$12.39K ≈ $8.76K |
AU$1.01 Million ≈ $717.19K |
-90.25pp |
| 2018-06-30 | 91.47% | AU$2.43 Million ≈ $1.72 Million |
AU$2.66 Million ≈ $1.88 Million |
+31.44pp |
| 2017-06-30 | 60.03% | AU$1.59 Million ≈ $1.12 Million |
AU$2.64 Million ≈ $1.87 Million |
+59.78pp |
| 2016-06-30 | 0.24% | AU$12.33K ≈ $8.73K |
AU$5.08 Million ≈ $3.59 Million |
-1.32pp |
| 2015-06-30 | 1.56% | AU$80.95K ≈ $57.28K |
AU$5.18 Million ≈ $3.67 Million |
+1.56pp |
| 2014-06-30 | 0.00% | AU$262.00 ≈ $185.38 |
AU$10.60 Million ≈ $7.50 Million |
-- |
About Respiri Ltd
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limi… Read more